The major histocompatibility complex class I heavy chain as a structural subunit of the human cell membrane insulin receptor: Implications for the range of biological functions of histocompatibility antigens ( 
NaDodSO4/PAGE, eluted from the gels, and found to react with monoclonal antibodies against monomorphic and a polymorphic MHC class I determinant known to be expressed on the cell line used as receptor source. Moreover, a murine thymoma line (RI) with MHC class I expression bound significant amounts of insulin, whereas a MHC class I-negative variant had low insulin binding capacity. Reduction in the density on human cells of the MHC class I heavy chain was obtained by capping with antibodies to fi2-microglobulin or to the MHC class I heavy chain and resulted in decreased insulin binding, whereas down-regulation of insulin receptors induced increased density of MHC class I molecules. It is concluded that the MHC class I heavy chain and the tetrameric insulin receptor are structurally associated in the cell membrane and suggested that this association may occur by displacement of .82-microglobulin by the insulin receptor.
The heavy chain of major histocompatibility complex (MHC) class I molecules normally associates in the membrane with 032-microglobulin (p82m) (1) (2) (3) (4) (5) , and an interchange between P32m in plasma and on cells takes place in vivo (6) (7) (8) . MHC class I molecules may also associate with other cell membrane components such as viral antigens (9-11). Ohno (12) has suggested that MHC class I molecules may serve as an anchorage protein in the membrane for organogenesis directing proteins (12) , and it has been suggested that biologically active insulin receptors may include the MHC class I heavy chain as a subunit (13) (14) (15) . This hypothesis was mainly based on experiments demonstrating interference of monoclonal antibodies against MHC class I molecules with insulin binding to viable cells and is supported by observations indicating a structural association between insulin receptors and MHC class I molecules on the surface of murine hepatocytes (16) .
We now report more extensive experimental support of this hypothesis. Reduction of the density of cell surface MHC class I molecules reduced the amount of functional insulin receptors, and down-regulation of insulin receptor expression increased the density of cell surface MHC class I molecules. Further, a monoclonal antibody with specificity for the insulin binding site on the a chain of the insulin receptor immunoprecipitated both the a and the /3 chain of the well-described tetrameric insulin receptor (17) (18) (19) and also molecules of Mr ""45,000. The latter molecules were shown to bind monoclonal antibodies against monomorphic and polymorphic class MHC I determinants. It is concluded that the MHC class I heavy chain can occur as a subunit of the insulin receptor on the intact cell surface.
MATERIALS AND METHODS
Cell Lines. Five established human cell lines were used: (i) U937 was established from a histiocytic lymphoma and has the phenotypic attributes of monocytes/macrophages (20) ; its HLA type is -A3, -B5,18, -Cwl; (ii) HL-60 is a promyelocytic leukemia line (21); (iii) IM-9 is a lymphoblastoid cell line (17) with HLA-A2,25, -B21,22, -Cw4; (iv) RH-L4 is a B-lymphoma line that expresses, but does not secrete, a fy heavy chain and K light chain (22) ; (v) Daudi is a Burkitt lymphoma line that is MHC class I negative (23) . A MHC class I-positive murine T-lymphoma cell line (RI) and a MHC class I-negative subclone (RIe) were used in some experiments (24) . All lines grow as floater cultures, are maintained in RPMI 1640 medium supplemented with 10-15% fetal calf serum and 0.03% L-glutamine, and are seeded at a density of 10'/ml and split at a cell concentration of 1-2 X 106/ml. Antibodies. Monoclonal antibodies (mAbs) against histocompatibility antigens were obtained from various sources. PA 2.6 (monomorphic MHC class I) and PA 2.1 (A2 of MHC class I) were obtained from P. Parham (Stanford University, CA) (25) , and BB 7.5 (monomorphic MHC class I), BB 7.7 (monomorphic MHC class I), BB 7.6 
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. Immunoprecipitation. Cells (2 x 106) were labeled with 125I by the Iodo-Gen procedure (Pierce) and solubilized in 1% Triton X-100/50 mM Hepes, pH 7.6/2 mM phenylmethylsulfonyl fluoride for -30 min at room temperature. Insoluble material was removed by centrifugation at 150,000 X g for 30 min at 4°C and the supernatant was incubated for 4 hr at 4°C with different antibodies. Immunoprecipitation with protein A-Sepharose was done by addition of protein A-coupled polyclonal rabbit anti-mouse Ig (DAKO). After 1 hr at 4°C, the immunoprecipitates were isolated by centrifugation at 300 x g for 1 min at 4°C and washed once with high-salt buffer (10 mM Tris HCl/1% Nonidet P-40/0.50 mM NaCl/2 mM EDTA/0.1% NaDodSO4) and twice with low-salt buffer (10 mM Tris HCl/1% Nonidet P-40/0.12 mM NaCl/2 mM EDTA/ 0.1% NaDodSO4). In some experiments, labeled cell extracts were preabsorbed with protein A-Sepharose CL4B-coupled polyclonal rabbit anti-mouse Ig. (Fig. 2) . However, co-capping of the MHC class I heavy chain occurred only for certain antibody dilutions and was (Fig. 2) . Reduction of the amount of MHC class I heavy chain was invariably associated with a reduction of insulin binding (Table 2) , whereas capping with antibodies to MHC class II molecules or to the transferrin receptor had no effect on insulin binding. No effects were observed on MHC class II antigens or on transferrin receptors after capping with antibodies to MHC class I molecules or P2m (data not shown).
RESULTS

Effect of Prior
Insulin Receptor Down-Regulation. The insulin receptor on IM-9 cells can be down-regulated by exposure of the cells to insulin (17) . Fig. 3 shows that down-regulation of the insulin receptor is associated with a marked decrease in binding of mAb 4F2, and a significant increase in binding of the anti-HLA-A3 mAb. Comparable results were obtained with mAb PA 2.6. The average number of total binding sites for insulin and for mAb PA 2.6 were estimated to 4 x 104 and 5 x 105, respectively. A complete down-regulation of the insulin receptor can therefore maximally result in an -10% increase in binding sites for anti-MHC class I mAbs.
Immunoprecipitation and Electroimmunoblotting. Immunoblots of a Triton X-100 extract of U937 cells and mAb 4F2 resulted in staining of one band with a Mr of =130,000 (Fig. 4) . mAb PA 2.6 could not be used in immunoblots but tFITC-labeled insulin was prepared as described (30) and used to estimate the number of insulin binding sites on viable cells.
immunoprecipitated from "25I-labeled cell membrane material of U937 cells a distinct band with a Mr of -45,000, and faint bands in the area of Mr -90,000 and 130,000. From the same iodine-labeled U937 cell membrane material, mAb 4F2 precipitated a prominent band at Mr -45,000 and distinct, although weaker, bands of Mr -90,000 and 130,000. The Mr 45,000 band was eluted from NaDodSO4/PAGE gels and found in a dot-blot assay to bind the mAb GAP A3 (Fig. 4) , which is specific for A3 of HLA (U937 cells are HLA-A3 positive). mAb PA 2.6 reacted with proteins that immunoprecipitated with mAb 4F2 from U937 cells before Fluorescence intensity B NaDodSO4/PAGE, whereas denaturation of the precipitate resulted in loss of this reactivity (Fig. 4) (36) , epidermal growth factor (37) , and insulin (13) (14) (15) in such a way as to influence the binding of the respective peptide ligands. In the case of -endorphin, however, the data suggest a direct binding of this peptide to the polymorphic part of the MHC class I molecule itself (38) . Studies on the insulin receptor are so far the most compelling with respect to an interaction in the membrane, and even in detergent-solubilized liver cell membranes, between MHC class I molecules and a hormone receptor (15) . The present work extends earlier studies of insulin binding to human cells (13) (14) (15) (Fig. 2) . The simplest explanation for the capping effect seems therefore to be that the binding of insulin is furthered by association in the membrane of the insulin receptor with MHC class I molecules. Hence, the sudden and massive removal of MHC class I molecules by capping will necessarily decrease the amount available and thus reduce insulin binding.
The role played by /32m during the postulated formation of physiologically active MHC class I molecules and insulin receptors is conjectural. Our favored hypothesis (13) (14) (15) NaDodSO4/PAGE, gave bands corresponding in position to the a and P chains of the insulin receptor, as well as a Mr 45,000 band, but no 82m band. However, in an immunoblotting experiment, mAb 4F2 stained the putative a chain of the insulin receptor exclusively. The assumed specificity of mAb 4F2 is further supported by the fact that its binding to the cell is markedly reduced by down-regulation of the receptor with insulin and by its blocking effect on insulin binding (15) .
We conclude that the insulin receptor associates structurally with MHC class I molecules in the membrane and that the complex thus binds insulin with high affinity. Whether the influence of MHC class I molecules on insulin binding is by conformational change in the insulin receptor molecule or by another mechanism remains to be elucidated.
